Long-term treatment of refractory neonatal hypoglycemia with long-acting somatostatin analog
- 31 October 1987
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 111 (4), 548-551
- https://doi.org/10.1016/s0022-3476(87)80118-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Normalization of glucose homeostasis by a long-acting somatostatin analog SMS 201-995 in a newborn with nesidioblastosisActa Endocrinologica, 1986
- The Role of a Long-Acting Somatostatin Analogue (SMS 201-995) in the Management of a Patient with a Benign Insulin-Secreting Adenoma of the Pancreas and a Postoperative Pancreatic FistulaScandinavian Journal of Gastroenterology, 1986
- Malignant Insulinoma: Effects of a Somatostatin Analog (Compound 201-995) on Serum Glucose, Growth, and Gastro-Entero-Pancreatic HormonesAnnals of Internal Medicine, 1985
- EFFECT OF SOMATOSTATIN INFUSION ON INTERMEDIARY METABOLISM AND ENTERO‐INSULAR HORMONE RELEASE IN INFANTS WITH HYPERINSULINAEMIC HYPOGLYCAEMIAActa Paediatrica, 1981
- Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia.Archives of Disease in Childhood, 1981
- Treatment of intractable neonatal hypoglycemia with somatostatin plus glucagonThe Journal of Pediatrics, 1980
- Case 30-1978New England Journal of Medicine, 1978
- Hypoglycemia of Infancy and NesidioblastosisNew England Journal of Medicine, 1977
- Neonatal and Infantile Hypoglycemia Due to Insulin ExcessAnnals of Surgery, 1977